Royalty Pharma plc — Director's Dealing 2025

May 9, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Royalty Pharma plc (RPRX)
CIK: 0001802768
Period of Report: 2025-05-08

Reporting Person: Legorreta Pablo G. (Director, CEO, Chairman of the Board)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-05-08	Class A Ordinary Shares	A	288352	—	Acquired	352147	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Class A Ordinary Shares	460139	Indirect
Class A Ordinary Shares	123310	Indirect
Class A Ordinary Shares	118500	Indirect
Class A Ordinary Shares	1040410	Indirect
Class A Ordinary Shares	901590	Indirect
Class A Ordinary Shares	41306	Indirect
Class A Ordinary Shares	6930	Indirect
Class A Ordinary Shares	292190	Indirect
Class A Ordinary Shares	10000	Indirect
Class A Ordinary Shares	10000	Indirect
Class A Ordinary Shares	600000	Indirect

Footnotes

F1: Reflects the exempt acquisition by the Reporting Person pursuant to Rule 16b-3 of Class A Ordinary Shares of the Issuer in connection with the settlement of Equity Performance Awards.